SwissNeuroRehab HDHI — High-Dose, High-Intensity Stroke Rehabilitation Program
Official title: SwissNeuroRehab - High Dose High Intensity Neurorehabilitation Along the Continuum of Care
Run by Centre Hospitalier Universitaire Vaudois · NCT07427511 · Data updated 2026-11-12
This program tests whether a structured, device-supported high-dose, high-intensity therapy plan can improve motor recovery for adults with subacute or chronic stroke across inpatient, outpatient, and home settings in Switzerland.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Centre Hospitalier Universitaire Vaudois Academic / other |
| Locations | 5 sites (Vitznau, Canton of Lucerne and 4 other locations) |
| Status | Recruiting |
| Started | February 10, 2026 |
| Main results expected | May 31, 2028 |
| Study ends | May 31, 2028 |
| Registry record updated | March 10, 2026 |
| Trial ID | NCT07427511 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–85 with a confirmed ischemic or hemorrhagic stroke more than 7 days prior who can sit unassisted, have motor difficulties in an arm or leg, and are willing to commit to the program and assessments are the ideal candidates.
✕Probably not a fit
Patients with severe cognitive impairment, uncontrolled seizures, severe neglect, plegia of the affected limb, or other medical conditions that limit safe participation are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicentre, non-randomised interventional feasibility project run within the SwissNeuroRehab network that implements a structured high-dose, high-intensity (HDHI) therapy pathway using CE‑marked digital neurorehabilitation tools. The pathway is designed for delivery across inpatient, outpatient, and home environments at several Swiss rehabilitation centres. Adults with ischemic or hemorrhagic stroke who can sit unassisted and have upper and/or lower limb motor difficulties are enrolled and asked to commit to a daily training dose and program length. Feasibility measures and preliminary clinical outcomes are collected at the start and end of the program to inform wider implementation.
Why it matters
Potential benefit: If successful, the program could accelerate and increase motor recovery and daily-function gains after stroke by delivering a higher, technology-supported therapy dose across care settings.
How similar studies have gone: Previous research on high-dose, high-intensity and device-assisted neurorehabilitation has shown promising motor improvements, though large-scale real-world implementation across care settings remains less established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18-85 years. * Confirmed diagnosis of stroke (ischemic or hemorrhagic) \>7 days ago * Be able to sit unassisted * Able and willing to give informed consent * Have motor difficulties of the Upper Extremity and/or Lower Extremity * Willing to commit to program length \& daily training dose * Willing to have assessments at start and end of program * Signed informed consent Exclusion Criteria: * Severe cognitive impairment * Uncontrolled seizure disorder or epilepsy - clinician's judgement) * Any medical condition that would compromise their safety (inability to communicate, vision or hearing impairment, heart condition that limits participation in exercise) and tolerability (cardiac contraindications) * Pain that would limit rehabilitation dose * Severe apraxia * Severe memory disorder * Severe hemispatial neglect * Plegia of the affected limb
Where it's running
-
Klinik Valens
Valens, Canton of St. Gallen, Switzerland Recruiting -
Centre hospitalier universitaire Vaudois
Lausanne, Canton of Vaud, Switzerland Recruiting -
Swiss Réhabilitation Sàrl
Sullens, Canton of Vaud, Switzerland Recruiting -
Lake Lucerne Institute
Vitznau, Canton of Lucerne, Switzerland Not yet recruiting -
Universitätspital Zürich
Zurich, Canton of Zurich, Switzerland Not yet recruiting
Study contacts
- Study coordinator: Olivier Bill, MD
- Email: olivier.bill@chuv.ch
- Phone: +41 0213141260
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Dual-task balance training plus computer-based cognitive training after stroke
In adults who recently had a stroke, the study tests whether adding computerized cognitive exercises to balance training improves balance and other recovery outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.